Half Yearly Report

RNS Number : 1648T
RWS Holdings PLC
02 June 2009
 



 

    2 June 2009


RWS Holdings plc


Interim results for the six months to 31 March 2009



RWS Holdings plc, Europe's leading provider of intellectual property support services (patent translations and technical searches) and technical translations, today announced its interim results for the six months ended 31 March 2009.


Financial Highlights:

Currency drives further growth


  • Sales for the period exceeded budget and were in line with 2008 at £26.8M after the full London Agreement impact
  • Profit before tax* for the period rose by 17.1% to £8M (2008: £6.8M)
  • Good operational performance enhanced by favourable exchange rates
  • Normalised earnings per share* were up 21.6% to 13.5p (2008: 11.1p)

  • Interim dividend increased by 12% to 2.8p (2008: 2.5p)
  • Cash generation from operations resulted in net cash at period end of £24.5M (2008: £17.9M), after acquisition costs of £2.2M

  • Release of corporation tax provision of £4.4M following agreement with HMRC, in respect of capital gains in 2003

  • Significant reduction in interest income due to lower interest rates


* before amortization of intangibles


 

Operational Highlights:

Resilience in a challenging economic environment


  • Solid performance in core patent translations business in spite of London Agreement
  • Acquisition of Communicare Limited in March 2009
  • PatBase subscription revenues grew 76%, well ahead of expectations
  • Fourth Queen's Award for Enterprise - International Trade


Current Trading:


  • Firm trading in the opening weeks of the second half of the year
  • Economic climate remains challenging in key markets

  

Executive Chairman Andrew Brode commented:


'The Group has again achieved record results and exceeded the Board's expectations, albeit assisted by the weakness of sterling.


The acquisitions of Communicare (and Document Service Center in 2008) will mitigate the effects of the London Agreement. In a challenging economic climate, our strong financial situation and market leadership position us favourably to grow market share and profits. The second half of the year has begun well.'



For further information contact:


RWS Holdings plc

Andrew Brode, Executive Chairman    01753 480200


Smithfield

Reg Hoare / Rebecca Whitehead        020 7360 4900


Numis

Stuart Skinner (Nominated Adviser)    020 7260 1000

James Serjeant (Corporate Broker)


About RWS:


RWS is Europe's leading provider of intellectual property support services (patent translations and technical searches) to the medical, pharmaceutical, chemical, aerospace, defence, automotive, electronics and telecoms industries. RWS also provides specialist technical, legal and financial translation services for areas of industry outside the patent arena. RWS is based in the UK, with offices in Europe, New YorkTokyo and Beijing, and is listed on AIM, the London Stock Exchange regulated market (RWS.L).


Approximately 1,000,000 patent documents are published per annum, 200,000 of which are published in Europe (Source: European Patent Office) and the intellectual property market has shown significant growth in recent years, with patent applications in Europe having doubled over the last ten years.


For further information please visit: www.rws.com

  

RWS GROUP

    2 June 2009


RWS Holdings plc


Interim results for the six months to 31 March 2009




Executive Chairman's Statement


The Group has again achieved record results for the six months to 31 March 2009, which reflect solid organic performances across many of the Group's activities. The anticipated loss of revenues arising from the London Agreement has been successfully countered by the Group's acquisitions and favourable exchange rates.


Business Overview


RWS is Europe's leading provider of intellectual property support services and high level technical, legal and financial translation services. Its main business - patent translations - is the largest operation of its kind in Europe, translating over 50,000 patents and intellectual property related documents each year. It addresses a blue chip multinational client base from Europe, North America and Japan, active in patent filing in the medical, pharmaceutical, chemical, aerospace, defence, automotive and telecoms industries, as well as patent agents acting on behalf of such clients. The Group has two principal business activities; Translations, which accounts for over 90% of sales and incorporates patent, commercial and technical translation services, and Information, which includes a comprehensive range of patent search, retrieval and monitoring services as well as PatBase, the largest searchable commercial patent database, available as a subscription service.


Strategy


Our strategy is focused upon organic growth complemented by deploying our substantial cash holdings for selective acquisitions providing they can be demonstrated to enhance shareholder value. Organic growth has been driven by the increasing numbers of patent applications worldwide, the growing demand for language services and our ability to enhance our market share by exploiting our leading position and reputation in an otherwise fragmented sector.


In terms of acquisitive growth, having been pleased with the return on acquisitions made to date, we continue to search for suitable potential acquisitions in the high level technical translation and intellectual property support services spaces. We seek niche businesses capable of delivering well above industry average levels of profitability.


Results & Financial Review


Sales for the six months ended 31 March 2009 were in line with the prior year at £26.8M despite the full impact of the London Agreement. This result exceeded the Board's expectations and was due in no small measure to favourable currency trends.


Profit before tax and amortization of intangibles rose by 17.1% to £8M (2008: £6.8M) as a result of further margin improvement, assisted by currency rates.


Normalised earnings per share were up by 21.6% to 13.5p (2008: 11.1p) on an increased number of shares in issue following the exercise of options in Summer 2008. Earnings per share as disclosed in the accounts of 24.2p (2008: 11.4p) have been significantly enhanced by the release of a corporation tax provision of £4.4M following agreement with HMRC in respect of capital gains realised in 2003.


Our strong financial position has been further enhanced both through operational cash flow and the release of the tax provision above. At 31 March 2009, shareholders' funds had reached £44.8M (2008: £31.4M), of which net cash represented £24.5M. Significant outlays included the acquisition of Communicare Limited for £2.2M and the final dividend of £3.3M paid in February 2009. Free cash flow made a further substantial advance to £7.2M (2008: £5.3M). Capital expenditure of £167,000 was again modest. The net working capital increase necessary to fund the business was £0.2M.


Currency movements in the period were generally favourable to a business reporting in sterling. The Group's principal exposure is to Euros, with somewhat less activity transacted in Yen, US$ and Swiss Francs. Without exception, these exchange rates rose from the beginning of October 2008 to levels well above those assumed by management in setting its budget for 2008/09. At 30 September 2008 the Euro/GBP rate was 79.4, whilst the average rate for the period was 87.9 At present, US$ exposure is hedged at 1.60 = £1, but other currencies have not been hedged.Our hedging policy is kept under continual review.


Interest income on the Group's substantial cash balances reduced significantly as the Bank of England cut base rates. This trend will be more marked in the second half.


Dividend


The Directors have approved an interim dividend of 2.8 pence per share, an increase of 12% over the 2008 interim dividend of 2.5 pence per share. The dividend will be paid on 17 July to shareholders on the register on 19 June 2009. In line with our progressive dividend policy, we expect the total dividend for the year to continue to advance in line with the Group's growth for the year as a whole.


Operating Review


Translations


The patent translations business, which accounts for almost 70% of Group revenues, demonstrated its defensive qualities in the face of the anticipated loss of sales revenues from the first full six month period of the London Agreement. RWS' high quality and competitive 'translate and file' service, which was developed in a European context, has now been extended to Japan and China with increasing interest being shown by North American and European multinational corporates. The US market is of particular promise to RWS and we have both enhanced our direct sales effort as well as partnering with a US-based consultancy focused on delivering cost saving patenting solutions to large filers.


Our commercial translation services account for 26% of Group revenues. These are non patent related services (medical, legal, financial and other technical translations) where we do experience significant levels of competition and where the current economic environment has proved to be challenging. We acquired Document Service Center (DSC), a Berlin-based provider of technical translations in February 2008 for £5.8M net. The performance of DSC has been impacted by its exposure to German exporters, but it has nevertheless been an earnings enhancing acquisition. We also announced on 3 March 2009 the acquisition of Communicare Limited, a London-based provider of medical and life sciences translations for £2.2M. At this very early stage, we fully anticipate that Communicare will be earnings enhancing in the current year.


Information


The information services business accounts for less than 10% of sales but a somewhat higher proportion of profit. The core patent search and watch services have suffered reduced demand which we attribute to economic pressures on clients.


The PatBase database subscription service has enjoyed further worldwide subscriber interest. We invested last year in improving its coverage and searchability. This investment has paid dividends in the form of a 76% growth in subscription revenues in the period, well ahead of our expectations. The scaleability and operational gearing of PatBase should ensure that it becomes a meaningful contributor to Group profit in the near future.


People


As is to be expected from a business support services leader, success derives from the quality of our staff. This is especially the case in times of economic challenge. As at 31 March 2009, the Group employed 425 people, similar to a year ago.


The announcement of a fourth Queen's Award for Enterprise - International Trade bears testimony to the outstanding contribution of our people.


Current Trading and Outlook


We have seen solid trading in the opening weeks of the second half year. Overall, providing sterling remains relatively weak, we expect the second half to exceed the Board's expectations.


The economic climate remains challenging in all of our key markets. However, we believe that our strong financial position and market leadership will enable us to achieve further progress.




Andrew Brode
Executive Chairman  

   


2 June 2009


  


Consolidated Income Statement

for the six months ended 31 March 2009












Unaudited

6 months 
ended

31 March 
200
9


Audited

Year ended

30 Sept. 
2008

Restated

unaudited

 6 months ended

31 March 
2008


Note

£'000

£'000

£'000






Revenue


26,804

54,106

26,992

Cost of sales


(14,395)

  (31,746)

  (16,264)

Gross profit


12,409

22,360

10,728

Administrative expenses


(4,976)

  (9,598)

  (4,461)

Operating profit


7,433

12,762

6,267

Analysed as:





Operating profit before amortization of

customer relationships and trademarks



7,645


13,028


6,344

Amortization of customer relationships and trademarks

(212)

(266)

(77)

Operating profit


7,433

12,762

6,267

Finance income


368

919

500

Finance expense


(1)

(1)

(1)

Profit before taxation


7,800

13,680

6,766

Taxation credit/(charge)

2

2,179

(4,093)

(2,161)

Profit for the period


9,979

9,587

4,605

Attributable to:





Equity holders of the Company

6

9,979

9,587

4,605

Basic earnings pence per Ordinary share

4

24.2

23.5

11.4

Diluted earnings pence per Ordinary share 

4

23.6

22.7

10.9


 

Consolidated Statement of Recognised Income and Expense

for the six months ended 31 March 2009










Unaudited

6 months ended

31 March 2009


Audited

Year ended

30 Sept. 2008

Restated unaudited

 6 months ended

31 March 2008


Note

£'000

£'000

£'000






Profit for the period


9,979

9,587

4,605

Exchange gains on retranslation of foreign operations

6

1,901

667

350

Total recognised income and expense for the period

11,880

10,254

4,955

Attributable to





Equity holders of the Company


11,880

10,254

4,955

Minority interest


-

-

-


 

Consolidated Balance Sheet

31 March 2009








Unaudited

31 March 2009


Audited

30 Sept. 2008

Restated

unaudited

 31 March 2008


Note

£'000

£'000

£'000






Assets





Non-current assets





Goodwill


13,829

10,924

10,760

Intangible assets 


3,793

3,532

3,374

Property, plant and equipment


794

738

792

Deferred tax assets


1,034

1,265

1,333



19,450

16,459

16,259

Current assets





Trade and other receivables


11,067

10,861

12,243

Cash and cash equivalents

5

24,495

22,081

17,898



35,562

32,942

30,141

Total assets


55,012

49,401

46,400

Liabilities





Current liabilities





Bank overdraft

5

-

-

13

Trade and other payables


7,226

6,790

7,961

Income tax payable


1,991

5,328

6,080

Derivative financial instruments


-

-

11



9,217

12,118

14,065

Non-current liabilities





Deferred tax liabilities


989

884

935



989

884

935

Total liabilities


10,206

13,002

15,000

Total net assets


44,806

36,399

31,400

Equity





Capital and reserves attributable to equity holders of the Company



Share capital


2,065

2,065

2,052

Share premium 


3,401

3,401

3,123

Reverse acquisition reserve


(8,483)

(8,483)

(8,483)

Foreign currency reserve


2,583

682

365

Retained earnings


45,230

38,724

34,333



44,796

36,389

31,390

Minority interest


10

10

10

Total equity

6

44,806

36,399

31,400


  


Consolidated Cash Flow Statement

for the six months ended 31 March 2009








Unaudited

6 months ended

31 March 2009



Audited

Year ended

30 Sept. 2008

Restated

unaudited

 6 months 
ended

31 March 2008


Note

£'000

£'000

£'000






Cash flows from operating activities





Profit before taxation


7,800

13,680

6,766

Adjustments for:





Depreciation of property, plant and equipment


151

315

154

Amortization of intangible assets


267

359

77

Finance income


(368)

(919)

(500)

Finance expense


1

1

1

Other non-cash movements


-

-

(147)

Operating cash flow before movements





in working capital and provisions


7,851

13,436

6,351

(Increase)/decrease in trade and other receivables


(36)

402

(945)

Increase in trade and other payables


289

244

1,492

Cash generated from operations


8,104

14,082

6,898

Interest paid


(1)

(1)

(1)

Income tax paid


(1,176)

(4,119)

(1,953)

Net cash inflow from operating activities


6,927

9,962

4,944

Cash flows from investing activities





Interest received


418

889

459

Acquisition of subsidiary, net of cash acquired

7

(2,259)

(5,817)

(5,817)

Purchases of property, plant and equipment


(151)

(258)

(120)

Purchases of intangibles (computer software)


(16)

(202)

-

Net cash outflow from investing activities


(2,008)

(5,388)

(5,478)

Cash flows from financing activities





Proceeds from the issue of shares


-

458

167

Dividends paid


(3,263)

(3,647)

(2,621)

Net cash outflow from financing activities


(3,263)

(3,189)

(2,454)

Net increase/(decrease) in cash and cash equivalents

1,656

1,385

(2,988)

Cash and cash equivalents at the beginning of the period

22,081

20,389

20,389

Exchange gains on cash and cash equivalents


758

307

484

Cash and cash equivalents at the end of the period

5

24,495

22,081

17,885






Free cash flow





Analysis of free cash flow





Net cash generated from operating activities


8,104

14,082

6,898

Net interest received


417

888

458

Income tax paid


(1,176)

(4,119)

(1,953)

Purchases of property, plant and equipment


(151)

(258)

(120)

Purchase of intangibles (computer software)


(16)

(202)

-

Free cash flow


7,178

10,391

5,283


  

Notes


 Accounting policies


    Basis of preparation


The interim financial statements were approved by the Board of Directors on 1 June 2009 and the interim results for the half years ended 31 March 2009 and 31 March 2008 are neither audited nor reviewed by our auditors. The accounts in this interim report do not constitute statutory accounts in accordance with Section 240 of the Companies Act 1985. They do not include all of the information required for full annual financial statements, and should be read in conjunction with the consolidated financial statements of the Group for the year ended 30 September 2008. The Group's statutory accounts for the year ended 30 September 2008 have been filed with the Registrar of Companies.  The auditors have reported on the accounts for the year ended 30 September 2008; their report was unqualified, did not contain any statements under s237 (2) or (3) of the Companies Act 1985 and did not contain any matters to which the auditors drew attention without qualifying their report.


The financial information presented in this document has been prepared on the basis of the IFRS in issue that are either endorsed by the EU and effective at 30 September 2009 or are expected to be endorsed before the financial statements are approved and authorised for issue. Based on these adopted and unadopted IFRS, the directors have made assumptions about the accounting policies expected to be applied when the annual IFRS statements are prepared for the year ended 30 September 2009. In addition, the adopted IFRS that will be effective in the annual financial statements for the year ended 30 September 2009 are still  subject to change and to additional interpretations and therefore can not be determined with certainty. Accordingly, the accounting policies for that annual period will be determined finally only when the annual financial statements for the Group are prepared for the year ended 30 September 2009.


The comparatives for the six months ended 31 March 2008 have been restated in line with the accounting policies and IFRS adjustments determined finally in preparing the Annual Report for the year ended 30 September 2008. This has affected goodwill, intangibles acquired, deferred tax and employee related liabilities.

 

2 Taxation - the charge for the 6 months ended 31 March 2009 is at the likely effective tax rate that will be applicable for the whole year.

 

HM Revenue & Customs have now agreed capital losses that offset capital gains arising on the redemption of loan notes in the year ended 30 September 2004. Therefore, the provision of £4.4 million has been released against the current year tax charge.



3 Dividends

6 months ended

31 March 2009

Year ended

30 Sept. 2008

6 months ended

31 March 2008


pence per share



£'000

pence 

per share



£'000

pence per share



£'000








Interim for 2008: paid July 2008 (2007: 2.15 pence)

-

-

2.50

1,026

-

-

Final for 2008: paid February 2009 (2007: 6.50 pence)

7.90

3,263

6.50

2,621

6.50

2,621

Dividends paid to shareholders

7.90

3,263

9.00

3,647

6.50

2,621










An interim dividend of 2.80 pence per Ordinary share will be paid on 17 July 2009 to Shareholders on the register at 19 June 2009. This dividend, declared by the Directors after the balance sheet date, has not been recognised in these financial statements as a liability at 31 March 2009.


4    Earnings per Ordinary share


The Group shows both a basic and an adjusted earnings per share figure as the Directors believe that this information will be of interest to the users of the accounts in measuring the Group's performance and underlying trends.




6 months ended

31 March 2009


Year ended 

30 Sept. 2008

Restated

6 months ended 

31 March 2008


Earnings

£'000

EPS

Pence

Earnings

£'000

EPS

Pence

Earnings

£'000

EPS

Pence








Profit attributable to equity holders of the Company for basic earnings per share calculation


9,979


24.2


9.587


23.5


4,605


11.4

Amortization of customer relationships and trademarks (after taxation)


153


0.3


192


0.5


56


0.1

Exceptional tax credit (note 2)

(4,434)

(10.7)

-

-

-

-

Adjusted earnings

5,698

13.8

9,779

24.0

4,661

11.5








Basic diluted earnings

9,979

23.6

9,587

22.7

4,605

10.9








Adjusted diluted earnings

5,698

13.5

9,779

23.2

4,661

11.1


Basic and diluted earnings are based on the post-tax group profit for the period and a weighted average number of Ordinary shares in issue during the period calculated as follows:


 
Number of shares
6 months ended
31 March 2009
Number of shares
Year ended
30 Sept. 2008
Number of shares
 6 months ended
31 March 2008
 
 
 
 
 
 
 
Weighted average number of Ordinary shares in issue for basic earnings
 
41,303,988
 
40,790,376
 
40,394,812
Dilutive impact of share options outstanding
916,408
1,370,712
1,711,321
Weighted average number of Ordinary shares for diluted earnings
 
42,220,396
 
42,161,088
 
42,106,133

 


At 31 March 2009 there were unexercised options over a total of 1,011,980 (2008 - 1,270,533) Ordinary shares.


5 Cash and cash equivalents

6 months ended 

31 March 2009

Year ended 

30 Sept. 2008

 6 months ended 

31 March 2008


£'000

£'000

£'000





Cash at bank and in hand

16,995

19,621

6,198

Short-term deposits

7,500

2,460

11,700

Cash and cash equivalents

24,495

22,081

17,898

Bank overdrafts (secured)

-

-

13

Cash and cash equivalents in the cash flow statement

24,495

22,081

17,885


Short-term deposits have original maturity of three months or less.

  


6 Statement of changes in equity


6 months ended 

31 March 2009


Year ended 

30 Sept. 2008 

Restated

 6 months ended 

31 March 2008


£'000

£'000

£'000





Total equity at the beginning of the period

36,399

28,722

28,722

Profit for the period

9,979

9,587

4,605

Dividends (note 3)

(3,263)

(3,647)

(2,621)

Currency translation differences

1,901

667

350

Issue of shares

-

458

167

Equity element of deferred tax on share based payments


(210)


612


177

Total equity at the end of the period

44,806

36,399

31,400


    

7 Acquisition


On 3 March 2009, the Group acquired the entire share capital of Communicare Limited, whose principal activity is the provision of technical translations for the medical and pharmaceutical industries, for a cash consideration of £2,233,000.


A full evaluation of goodwill and the identification of the acquired intangible assets has not yet been completed. Pending this, the provisional fair value of identifiable assets and liabilities acquired, purchase consideration and goodwill are as follows: 





Book value

Provisional

fair value adjustments


Provisional

fair values


£'000

£'000

£'000





Net assets acquired:




Property, plant and equipment

22

-

22

Trade and other receivables

206

-

206

Corporation tax debtor

10

-

10

Overdrafts

(26)

-

(26)

Trade and other payables

(146)

-

(146)


66

-

66

Goodwill



2,167

Total consideration



2,233

Satisfied by:




Cash



2,122

Directly attributable costs: legal and professional fees



111

Total consideration 



2,233





Cash flow:




Total consideration



2,233

Overdraft included in undertaking acquired



26

Net cash consideration in cash flow statement



2,259



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR ILFFDRLILIIA

Companies

RWS Holdings (RWS)
UK 100

Latest directors dealings